SynthesisEndocrinology and metabolism (Seoul, Korea)2024

Efficacy and Safety of Omarigliptin, a Novel Once-Weekly Dipeptidyl Peptidase-4 Inhibitor, in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.

A B M Kamrul-Hasan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.